Virginia Hospital Center, a 394-bed nonprofit hospital in the Washington, DC area, is implementing the Spok Care Connect platform for hospital communication. The organization is planning a hospital-wide rollout of the smartphone-based secure messaging platform.
“Two years ago, we decided to invest in a new EHR and now, interoperability is a top priority for us,” Michael Mistretta, vice president...
A newly announced study backed by Takeda Pharmaceuticals, Lundbeck US, and Advocate Health Care will explore the effectiveness of a mobile app designed to improve engagement between patients with major depressive disorder (MDD) and their providers.
The investigation will use the Advocate Pathway App to capture the start of or any adjustments to a patient’s antidepressant therapy. Through a...
Like many cognitive illnesses, clinical depression isn’t a steady state but a variable condition that has patterns and symptoms that change over time and throughout daily life. So Takeda Pharmaceuticals and Cognition Kit are collaborating on a study to assess whether mobile apps and wearables with continuous monitoring capabilities can be used to glean new insights into major depressive disorder...
Pharmaceutical company Takeda is looking to up its digital strategy game, pairing with a few companies to advance clinical trials, analyze data and develop biosensor and wearable technology.
Takeda has adopted the platform of Koneska Health, an early stage technology company that works with data gathered through mobile, wearable and other digital technologies to measure health indicators, to...
Litmus Health, a company helping pharma companies use wearable devices to improve the efficiency of Phase I and II drug trials, is coming out of public beta and announcing a trial with the University of Chicago testing the effects of activity, sleep, and diet on Inflammatory Bowel Disease (IBD) patients. The trial is funded via a grant from Takeda Pharmaeuticals.
"I see so many patients filling...
